What ALBANY MOLECULAR RESEARCH INC's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| D Ambra Thomas E Phd | Director | Aug 31 | Disposition to Issuer · D | −2,393,339 | $21.75 | −$52.1M | 0 |
| Ladin Felicia I | SVP, Treasurer & CFO | Aug 31 | Disposition to Issuer · D | −63,568 | $21.75 | −$1.38M | 0 |
| Ladin Felicia I | SVP, Treasurer & CFO | Aug 31 | Grant / award · A | +4,993 | — | — | 63,568 |
| Hagen Kenneth Paul | Director | Aug 31 | Disposition to Issuer · D | −6,838 | $21.75 | −$149K | 0 |
| Oconnor Kevin | Director | Aug 31 | Disposition to Issuer · D | −58,275 | $21.75 | −$1.27M | 0 |
| Conway Christopher M. | SVP, Discovery and Development | Aug 31 | Disposition to Issuer · D | −47,477 | $21.75 | −$1.03M | 0 |
| Conway Christopher M. | SVP, Discovery and Development | Aug 31 | Grant / award · A | +2,247 | — | — | 47,477 |
| Boyer Milton | SVP, Drug Product Manufacturin | Aug 31 | Disposition to Issuer · D | −42,109 | $21.75 | −$916K | 0 |
| Boyer Milton | SVP, Drug Product Manufacturin | Aug 31 | Grant / award · A | +3,199 | — | — | 42,109 |
| Henderson Lori M | SVP, Secretary & Gen Counsel | Aug 31 | Disposition to Issuer · D | −66,717 | $21.75 | −$1.45M | 0 |
| Henderson Lori M | SVP, Secretary & Gen Counsel | Aug 31 | Grant / award · A | +4,722 | — | — | 66,717 |
| Maddaluna Anthony J | Director | Aug 31 | Disposition to Issuer · D | −11,210 | $21.75 | −$244K | 0 |
| Marth William S | President and CEO | Aug 31 | Disposition to Issuer · D | −483,033 | $21.75 | −$10.5M | 0 |
| Marth William S | President and CEO | Aug 31 | Other Transaction · J | −20,383 | — | — | 483,033 |
| Marth William S | President and CEO | Aug 31 | Other Transaction · J | −18,472 | — | — | 503,416 |
| Hagen Steven R | SVP Manufacturing & Pharmaceut | Aug 31 | Disposition to Issuer · D | −43,655 | $21.75 | −$949K | 0 |
| Hagen Steven R | SVP Manufacturing & Pharmaceut | Aug 31 | Grant / award · A | +3,138 | — | — | 43,655 |
| Fine Margalit | Executive Vice President, API | Aug 31 | Disposition to Issuer · D | −23,543 | $21.75 | −$512K | 0 |
| Fine Margalit | Executive Vice President, API | Aug 31 | Grant / award · A | +2,318 | — | — | 23,543 |
| Fine Margalit | Executive Vice President, API | Aug 31 | Grant / award · A | +10,000 | — | — | 21,225 |
Loading...
